IP Library Granted Patent US 12,636,462
Granted Patent B2
US 12,636,462 · App. 16/607,951 · Granted May 26, 2026

Light therapy system and method

Inventors: Thomas Maria Falck (Aachen, DE); Antonius Fredericus Maria Dieu-donné Akkermans (Waalre, NL)
Assignee: Koninklijke Philips N.V.
A61M21/00A61M2021/0044
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,636,462
App. No.
16/607,951
Granted
May 26, 2026
Kind
B2
Abstract

A light therapy system ( 12 ) for administering a controllable melanopic luminous exposure includes a lighting assembly ( 16 ) for producing a light output ( 68 ) having a configurable illuminance and color temperature. Based on a received target melanopic luminous exposure a controller ( 24 ) of the system constructs a suitable control schedule ( 71 ) for controlling parameter levels of the lighting assembly over time such that in total over a defined treatment period ( 78 ), the indicated target melanopic luminous exposure is delivered. In constructing the control schedule, the relative melanopic sensitivity of humans to light of different color temperatures is taken into account. The color temperature of the administered light is accordingly controlled such that after adjusting for color, the delivered luminous exposure conforms to the input exposure target.

Claims (56)

1 . A light therapy system, comprising:

a lighting assembly operable to create a light output having a controllable illuminance and color temperature; and

a controller, operatively coupled to the lighting assembly, and adapted to:

receive a data input indicating a target melanopic luminous exposure for administration by the lighting assembly;

retrieve from a data store one or more melanopic weighting factors corresponding to a relative melanopic effect of different color temperatures of light;

create, based on the one or more melanopic weighting factors and based on a pre-stored schedule template including a fixed temporal portion, a control schedule for controlling the illuminance and color temperature values of the lighting assembly over time such as to deliver in total over a defined treatment period the target melanopic luminous exposure; and

control the lighting assembly in accordance with the control schedule.

2 . The light therapy system as claimed in claim 1 , wherein the controller is adapted to further receive color preference data indicating one or more preferred color temperature values, and to create the control schedule such that the color temperature of the light output, for at least a portion of the treatment period, has the one or more preferred color temperature values.

3 . The light therapy system as claimed in claim 1 , wherein the pre-stored schedule template also includes a configurable temporal portion, the controller being adapted to determine the configurable temporal portion and wherein the fixed temporal portion and the configurable temporal portion together are configured to deliver the target melanopic luminous exposure.

4 . The light therapy system as claimed in claim 3 , wherein the controller is adapted to create the control schedule such that an average illuminance level during the configurable temporal portion is higher than an average illuminance level during the fixed temporal portion.

5 . The light therapy system as claimed in claim 3 , wherein the pre-stored schedule template includes a plurality of configurable temporal portions, being separated by a plurality of intermediate fixed temporal portions.

6 . The light therapy system as claimed in claim 1 , wherein the controller is adapted to further retrieve from the data store an indication of an upper and lower limit for the illuminance of the light output during the treatment period and an indication of an upper and lower limit for a duration of at least a configurable temporal portion of the treatment period, and to create at least a configurable temporal portion of the control schedule in accordance with the illuminance and duration values.

7 . The light therapy system as claimed in claim 6 , further comprising:

a user input device for receiving said data input indicating the target melanopic luminous exposure; and

a user output device, wherein, in advance of receiving said target melanopic luminous exposure, the controller is adapted to:

determine, based upon said upper and lower limits for the illuminance and duration values, a maximum and minimum melanopic luminous exposure deliverable using the lighting assembly for each of a set of light color temperatures; and

control the user output device to communicate the maximum and minimum melanopic luminous exposure deliverable using the lighting assembly for each of the set of light color temperatures.

8 . The light therapy system as claimed in claim 6 , further comprising:

a user input device for receiving said data input indicating the target melanopic luminous exposure; and

a user output device, wherein the controller is further adapted to:

determine, based on the upper and lower limits for the duration and illuminance, maximum and minimum values of at least one of the following parameters sufficient to deliver the target melanopic luminous exposure:

color temperature of the light output during the at least a configurable temporal portion of the control schedule,

duration of the at least the configurable temporal portion of a control schedule, and

illuminance level of the light output during the at least a configurable temporal portion of the control schedule;

control the user output device to communicate the determined maximum and minimum values;

receive from the user input device a data input indicating a preferred value for one or more of said parameters; and

create the control schedule such that the light output, for at least a portion of the treatment period, is consistent with said preferred value.

9 . The light therapy system as claimed in claim 1 , wherein the data store is comprised by the controller or wherein the data store is remote from the light therapy system.

10 . The light therapy system as claimed in claim 1 ,

wherein the lighting assembly comprises a plurality of light sources each having a respective spectral emission profile, and

wherein control of the color temperature of the light output comprises determining, based on pre-stored configuration data, light levels for each of said plurality of light sources.

11 . The light therapy system as claimed in claim 1 further comprising:

an eye status sensor for detecting whether eyes of a user are open or closed, the eye status sensor being operatively coupled with the controller, and the controller being adapted to adjust a duration of, and/or the illuminance and/or color temperature of, the light output during at least a configurable temporal portion of the control schedule based on readings from the eye status sensor in order to ensure delivery of the target luminous exposure; and

optionally wherein the controller is adapted to calculate, based on the readings from the eye status sensor over a defined sensing period, an aggregate time period for which a user's eyes have been closed, and to extend the duration of the at least a configurable temporal portion of the control schedule by said aggregate time period.

12 . The light therapy system as claimed in claim 1 , further comprising:

a presence sensor, operatively coupled with the controller and arranged in use to detect a presence or an absence of a user within a light path of the lighting assembly, and

wherein the controller is adapted to adjust a duration of, and/or the illuminance and/or color temperature of, the light output during at least a configurable temporal portion of the control schedule based on readings from the presence sensor in order to ensure delivery of the target luminous exposure.

13 . The light therapy system as claimed in claim 1 , further comprising

a light level sensor, arranged to detect a light level proximal to a user, and

wherein the controller is adapted to adjust a duration of, and/or the illuminance and/or color temperature of, the light output during at least a configurable temporal portion of the control schedule based on readings from the sensor, in order to ensure delivery of the target luminous exposure, and optionally wherein the light level sensor is arranged proximal to a user's eye or eyes.

14 . The light therapy system as claimed in claim 1 , wherein the controller is further adapted to:

retrieve from the data store an indication of an age of a user;

retrieve from the data store a set of age weighting factors, being based on average sensitivity to light of users of different ages; and

adjust a duration of, and/or the illuminance and/or color temperature of, the light output during at least a configurable temporal portion of the control schedule based on the retrieved age and retrieved weighting factors in order to ensure delivery of the target luminous exposure.

15 . A light therapy method for controlling a lighting assembly to deliver a target melanopic luminous exposure, the lighting assembly being operable to create a light output having a controllable illuminance and color temperature, and the method comprising:

receiving a data input indicating a target melanopic luminous exposure for administration by the lighting assembly;

retrieving from a data store one or more melanopic weighting factors corresponding to a relative melanopic effect of different color temperatures of light;

creating, based on the one or more melanopic weighting factors and based on a pre-stored schedule template including a fixed temporal portion, a control schedule for controlling the illuminance and color temperature values of the lighting assembly over time such as to deliver in total over a defined treatment period the target melanopic luminous exposure; and

controlling the lighting assembly in accordance with the control schedule.

16 . The method as claimed in claim 15 , further comprising:

receiving color preference data indicating one or more preferred color temperature values; and

creating the control schedule such that the color temperature of the light output, for at least a portion of the treatment period, has the one or more preferred color temperature values.

17 . The method as claimed in claim 15 , wherein the pre-stored schedule template further comprises a configurable temporal portion, and the method further comprises determining the configurable temporal portion, and wherein the fixed temporal portion and the configurable temporal portion together are configured to deliver the target melanopic luminous exposure.

18 . The method as claimed in claim 17 , further comprising to creating the control schedule such that an average illuminance level during the configurable temporal portion is higher than an average illuminance level during the fixed temporal portion.

19 . The method as claimed in claim 17 , wherein the pre-stored schedule template includes a plurality of configurable temporal portions, being separated by a plurality of intermediate fixed temporal portions.

20 . The method as claimed in claim 15 , wherein the controller is adapted to further retrieve from the data store an indication of an upper and lower limit for the illuminance of the light output during the treatment period and an indication of an upper and lower limit for a duration of at least a configurable temporal portion of the treatment period, and to create at least a configurable temporal portion of the control schedule in accordance with the illuminance and duration values.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2021
From: FALCK, THOMAS MARIA; AKKERMANS, FREDERICUS MARIA DIEU-DONNE
To: KONINKLIJKE PHILIPS N.V.
Reel/Frame 057908/0615 →
Priority Claims (1)
EP 17167766 · Apr 24, 2017 · regional
Continuity (1)
Related Publication 20240216641A1 · Jul 4, 2024
References Cited (16)
US 10257902B2 · Trouwborst et al. · 2019 [cited by applicant]
US 20060009822A1 · Savage · 2006 [cited by examiner]
US 20120215290A1 · Chen · 2012 [cited by examiner]
US 20130293144A1 · Tomiyama · 2013 [cited by examiner]
US 20140052220A1 · Pedersen · 2014 [cited by examiner]
US 20150035440A1 · Spero · 2015 [cited by examiner]
US 20150126806A1 · Barroso · 2015 [cited by examiner]
US 20160129280A1 · Douglas · 2016 [cited by examiner]
CA 2829054A1 · 2012 [cited by applicant]
EP 2796166A1 · 2014 [cited by applicant]
WO 2013175348A1 · 2013 [cited by applicant]
WO WO2017192566A1 · 2017 [cited by examiner]
WO WO2021163343A2 · 2021 [cited by examiner]
Ono, H. et al., “The usefulness of bright light therapy for patients after oesophagectomy”, Intensive and Critical Care Nursing (2011) 27, 158-166. [cited by applicant]
International Search Report and Written Opinion, International Application No. PCT/EP2018/059621, Mailed on Jun. 11, 2018. [cited by applicant]
DIN SPEC 5031-100, Aug. 2015. [cited by applicant]